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Abstract
1,6-Diphenyl-1,3,5-hexatriene (DPH) is a commonly used fluorescence probe for studying cell membranelipids due to its affinity toward the acyl chains in the phospholipid bilayers. In this work, we investigated
its use in matrix-assisted laser desorption/ionization (MALDI) as a new matrix for mass spectrometry
imaging (MSI) of mouse and rat brain tissue. DPH exhibits very minimal matrix-induced background
signals for the analysis of small molecules (below m/z of 1000). In the negative ion mode, DPH permits
the highly sensitive detection of small fatty acids (m/z 200 – 350) as well as a variety of large lipids up to
m/z of 1000, including lyso-phospholipid, phosphatidic acid (PA), phosphoethanolamine (PE),
phosphatidylserine (PS), phosphatidylglycerol (PG), phosphatidylinositol (PI), and sulfatides (ST). The
analytes were mostly detected as the deprotonated ion [M–H]–. Our results also demonstrate that sublimated
DPH is stable for at least 24 h under the vacuum of our MALDI mass spectrometer. The ability to apply
DPH via sublimation coupled with its low volatility allows us to perform tissue imaging of the above
analytes at high spatial resolution. The degree of lipid fragmentation was determined experimentally at
varying laser intensities. The results illustrated that the use of relatively low laser energy is important to
minimize the artificially generated fatty acid signals. On the other hand, the lipid fragmentation obtained at
higher laser energies provided tandem MS information useful for lipid structure elucidation.

*Corresponding author Email: kyeung@uwo.ca
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Introduction
During the MALDI process,1 the matrix can play multiple roles including the mediator of energy transfer,
the proton donor and/or receptor and the analyte selector that gives rise to selectivity. Continuous effort in
exploring new matrices is desirable, not only to improve the quality of MALDI MS data based on the
analyte selectivity/specificity of the matrices2, but also to gain a better understanding of the analyte
desorption/ionization mechanism and analyte-matrix interactions.3 Generally, examples of ideal
characteristics of MALDI matrices may include: a strong absorption at the wavelength of the irradiating
laser,4 minimal background signals originated from the matrix and its clusters, the ability to co-crystallize
with the analyte and promote its ionization, negligible volatility at room temperature and high stability
under the vacuum of mass spectrometers. For MS imaging, it is also desirable for the matrix to be
compatible with application by sublimation, which produces the highly homogenous matrix layer required
for high spatial resolution.5
In the matrix-analyte cocrystallization step, it has been proven that thorough mixing and integration
between the matrix and the analyte molecules6 is crucial for obtaining both the optimal ionization of
analytes7 and the suppression of background matrix ion signals.8 In other words, it is ideal to select a matrix
with high chemical affinity and compatibility with the analytes of interest. For example, Fukuyama et al.
synthesized a novel matrix additive o-alkylated dihydroxybenzoic acid (ADHB) to increase the
hydrophobicity of the conventional 2,5-dihydroxybenzoic acid (DHB) and, thus, enhancing its affinity
toward hydrophobic peptides and improve the sensitivity.9 The authors claimed that ADHB enriches the
hydrophobic part and this enrichment depends on the degree of hydrophobicity. Similarly, Stoyanovsky
and co-workers investigated the application of DHB-CnH2n+1 (C6H13, C9H19 and C12H25) for MALDI-MSI
of phospholipids in brain tissue.10 Comparing to the conventional DHB, the modified DHB promoted the
formation of finer crystals through enhanced incorporation of the alkyl chains of DHB-CnH2n+1 into
hydrophobic phospholipid bilayers and resulted in improved spatial resolution.
Various phospholipids and fatty acids11 have been identified as biomarkers of diseases such as Alzheimer’s
disease,12 schizophrenia,13 coronary heart diseases,14 cancers15 and lacunar infarction.16 The development
in biomolecular imaging techniques enabled the revelation of spatial distribution of several lipids17 and
better understanding of their role in biological processes18 and diseases.19 DHB,17,20 9-aminoacridine (9AA)17,21 and 1,5-diaminonaphtalene (DAN)22 are the most widely used matrices for lipid MS imaging.
However, the MS imaging of fatty acids is more difficult owing to the following two challenges. First,
common matrices do not sufficiently facilitate the detection fatty acids via MALDI due to the intense
matrix-induced background signals at the same MW region as that of fatty acids and/or the poor ionization
2

efficiency of fatty acid molecules. 1,8-Bis(dimethylamino) naphthalene (DMAN) was reported as a “proton
sponge”, a super basic matrix suitable for MALDI MS analysis of metabolites,23 fatty acids24 and other
lipids.25 However, DMAN is not stable under high vacuum. That is, the deposited matrix is sufficiently
volatile at ambient temperature for it to sublime under the MALDI MS vacuum. DMAN coatings on sample
targets were reported to disappear completely after 60 min and thus cannot be used for imaging experiments
which are often longer than 1 h.22 Alternative to matrices of organic molecules, the use of metallic silver,
either as nanoparticle26,27 or metallic sputtered films28,29, was found effective for the laser
desorption/ionization (LDI) MS imaging of biological tissues. In particular, Hayasaka et al.27 reported the
use of silver nanoparticles for the visualization of fatty acids. Instead of discovering novel matrices, another
approach was to perform on-tissue chemical derivatization of fatty acids, with the intentions of enhancing
ionization efficiency and shifting the molecular mass of fatty acids away from the matrix background.30
The second and more problematic challenge is the inability to distinguish the signals from endogenous free
fatty acids in the tissue than those resulted from degradation or dissociation of lipids. Specifically, the
authors of both refs 27 and

30

acknowledged that the MS signals of fatty acids in their reports could come

from either: the desired free fatty acids present in the samples, or the undesired fragments dissociated from
lipids either in gas phase during ionization/desorption or on-tissue during sample preparation and/or matrix
application. To minimize this fragmentation, Wu and co-workers published the use of dopamine-modified
TiO2 monolith for LDI MS imaging of small metabolites, fatty acids and lipids. Using dopamine as a ligand
allowed them to shift the UV absorption of TiO2 toward the laser emission wavelength and increase the
sensitivity and to increase the pH of the tissue surface and minimize the hydrolysis of lipids.31
In this paper, we propose the use of commercially available 1,6-diphenyl-1,3,5-hexatriene (DPH) as a novel
matrix for MALDI MS imaging analysis of a variety of fatty acids and lipids, without the need of any
chemical derivatization. DPH is a polyene hydrocarbon compound and is one of the most widely used
fluorescent probes in studies of biological membranes32 and phospholipids bilayer.33 Due to the continuous
pi bonds (C6H5-CH=CH-CH=CH-CH=CH-C6H5), DPH has three vibrational peaks, its absorption band
ranges from 330-380 nm,34 which matches the emission wavelengths of common MALDI lasers. Consisting
of only hydrocarbons in a nonpolar configuration, DPH exhibits high hydrophobic affinity toward the alkyl
chains in the lipids,35 which is supported by the well-documented DPH integration within cell membranes.36
DPH was also generally used in lipid detection for its emission enhancement in the presence of
phospholipids and triglycerides compounds in aqueous media.37 In addition, it was shown that DPH can
transfer its excitation energy to nearby acceptor molecule (chromophore).38 All the above criteria support
DPH being an excellent candidate as a matrix for the detection of fatty acids and phospholipids by MALDIMS. To the best of our knowledge, this is the first report of applying DPH as a matrix for MALDI MS and
3

MSI analyses. Experiments will be presented in this paper to demonstrate that DPH is a suitable and
effective matrix to facilitate the MALDI MS imaging of lipids in rat and mouse brain tissues, including a
variety of lipids: fatty acids (FAs), lyso-phospholipids (L-PLs), phospholipids (PLs), and sulfatides (STs).
The degree of lipid fragmentation with DPH as matrix will also be investigated for its application in the
MALDI MS tissue imaging of free fatty acids.
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Materials and Methods
Chemicals. Liquid chromatography grade solvents, methanol, ethanol, chloroform, and tetrahydrofuran
(THF), were purchased from Sigma-Aldrich (Oakville, ON, Canada). Various matrices, 9-aminoacridine
(9-AA),

1,5-diaminonaphthalene

(DAN),

2,5

dihydroxybenzoic

acid

(DHB),

1,8-

bis(dimethylamino)naphthalene (DMAN), α-cyano-4-hydroxycinnamic acid (CHCA), 1,6-diphenyl-1,3,5hexatriene (DPH), and fatty acid standards, hexanoic, palmitic, and arachidic acids, were also purchased
from Sigma-Aldrich. DPH was recrystallized using acetone prior to use. Briefly, 5 g of DPH were dissolved
in about 125 mL of acetone at its boiling point (56°C). The hot solution was filtered to remove insoluble
impurities. Crystals were formed as the solution cooled to room temperature. They were isolated by
filtration and dried.
Lipid standards were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA), including, 1,2dilauroyl-sn-glycero-3-phosphocholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA, as
sodium salt), 1-palmitoyl-2-hydroxy-sn-Glycero-3-phosphate (lyso-PA 16:0), 1-(1z-hexdecyl)-sn-glycero3-phosphocholine (lyso-PC 16:1), 1,2-distearoyl-sn-Glycero-3-Phosphoethanolamine (DSPE), 1,2distearoyl-sn-glycero-3-[Phospho-rac-(1-glycerol)] (DSPG, as sodium salt) and 1,2-dioleoyl-sn-glycero-3[phospho-L-serine] (DOPS, as sodium salt).
Stock solutions were prepared at a concentration of 0.5 mg/mL in various solvent mixtures: ethanol for
fatty acids, methanol for lyso-PA, DMPA and DLPC, a methanol-to-chloroform of 1:1 for DSPG, DSPE
and DOPS, and chloroform for lyso-PC. Solutions of DPH were prepared in THF. Solutions of 9-AA,
CHCA, DAN, DHB and DMAN were prepared in methanol.
Sample Preparation for Standards. Dried droplet preparations were performed; equal volumes from
analyte and matrix solutions are mixed, then 0.75 µL was deposited on the target and allowed to dry. For
individual standards analysis, the deposited amount of analyte is 0.5 nmol. For the analyses of phospholipid
mixture standards, in comparing the effect of organic matrices, the deposited amount of each phospholipid
was 50 pmol.
Tissue Sample Preparation. Brains from male of C57BL/6 mice and Wistar rats (aged 6 months) were
used for tissue sections. The brains were flash-frozen in dry ice immediately after dissection and stored at
−80 °C until use. They were attached to a specimen holder on dry ice with distilled water. Using a cryostat
(CryoStar NX50, ThermoFisher Scientific, Burlington, ON, Canada), 10 µm thick coronal and sagittal brain
sections were thaw-mounted onto indium tin oxide coated glass slides (Hudson Surface Technology Inc.,
5

Fort Lee, NY, USA). Slides were dehydrated for 5 – 10 min in a vacuum chamber and then coated with
DPH matrix using a sublimation apparatus (Chemglass Life Sciences, Vineland NJ, USA). Following
matrix application, a mixture of lyso-PA and the calibration standard kit (SCIEX, Concord, ON, Canada)
was mixed with CHCA, and 0.75 µL spots were applied on DPH matrix-free areas of the glass slide in the
vicinity of the section to be imaged. After the calibration spots dried, glass slides were dehydrated in a
vacuum chamber for 5 – 10 min.
Matrix Sublimation. The sublimation protocol used by this research group was previously reported.39 The
amount of matrix, temperature and duration were reoptimized for DPH: 250 mg DPH at 200 °C for 3.0 min.
These conditions produced a uniform layer of matrix crystals on the entire surface of ITO glass. The
sublimation time was also optimized by examining the total ion counts (TIC) between the m/z range of 600
to 1000 from mouse brain tissue covered with various thicknesses of DPH. The TIC recorded were 0.005,
0.010, 0.025, 0.020 and 0.018, respectively from DPH coverages of 70, 85, 90, 120, and 150 µg per cm2.
Hence, the coverage of 90 µg per cm2, resulted from a sublimation time of 3.0 min was deemed optimal.
With the naked eyes, an optimal coating of matrix was thick enough to appear as a translucent coating, yet
sufficiently thin to allow the shape and details of brain to remain visible.
MALDI MS, MSI and MS/MS. MS data were obtained using a SCIEX 5800 MALDI TOF-TOF mass
spectrometer. The instrument is equipped with a 349 nm Nd:YLF “OptiBeam On-Axis” laser. The laser
pulse rate used was 400 Hz. Data acquisition and processing of profiling data were respectively done using
a TOF-TOF Series Explorer and Data Explorer (SCIEX). ITO-coated glass slides with tissue sample
sections were mounted onto a MALDI plate adapter and loaded into the mass spectrometer. Following the
external calibration at ±50 ppm mass tolerance, images were acquired in reflectron negative ion mode, with
70-80 µm laser steps. The laser energy was optimized in MSI experiments to procedure sufficiently high
signal intensities for fatty acids and minimal the fragmentation of lipids. For the results presented in this
paper, the laser intensities used were typically around 2600 (arbitrary unit). However, this number will
vary with the age of the laser. The detector multiplier was set at 1.89 V for MS mode. A mass range between
m/z of 200 – 1000 was acquired. All experiments were repeated at least three times to ensure
reproducibility.
Negative ion MS/MS mode experiments were conducted with 10 to 20% higher laser energy compared to
the MS mode, in order to promote fragmentation of the analytes of interest for structural identification.
The detector multiplier voltage was also maximized at 2.25 kV for MS/MS mode. Following the external
calibration at ±50 ppm tolerance, the precursor ion was isolated within an m/z window of ±0.2 Da and
fragmented in a postsource decay mechanism. Besides the MS/MS experiments, lipid characterization was
6

performed by comparing accurate mass measurements with the LIPID MAPS prediction tool
(http://www.lipidmaps.org/tools/index.html). Certain peak assignments were based on work reported by
Wang et al.40

Processing of Molecular Image Data. MS imaging data were visualized using MSiReader (Version
0.06).41 The images presented in this paper have not been smoothed, normalized, or preprocessed. All
images were normalized for visualization of expression; that is, the same shades and colors from different
images do not reflect the same absolute signal intensities.
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Results and Discussion
DPH as a Matrix for MALDI MS
DPH has a strong absorption in the region between 330 and 380 nm, and it is a common fluorescence probe
for studying the membrane cell due to its high affinity to acyl chains.34 Such characteristics of DPH
prompted us to investigate its application as a MALDI matrix for the detection of fatty acids and
phospholipids. However, the strong UV-absorptivity of DPH may also give rise to the formation of
abundant metastable matrix cluster ions during the laser desorption/ionization process, resulting in “noisy”
backgrounds. Therefore, our initial experiment was to record the DPH matrix background MALDI MS
signals in both positive and negative ion modes. The spectra are respectively presented as Figure 1 a and
b. In the positive ion mode, the background spectrum is extremely clean and primarily dominated by the
DPH radical ion [M·]+ at m/z of 232.1 (Figure 1a). In negative ion mode, the DPH background spectrum
is more complex (Figure 1b). The most intense peak is from the deprotonated DPH ions, [M–H]–, at m/z of
231.2. The peak at m/z 233.2 is also intense, which corresponds to radical ion [M+H·]-. The additional
peaks with m/z larger than m/z 233.2 were not identified, but were speculated to be impurities, clusters, or
adducts of DPH.
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Figure 1. MALDI-TOF mass spectra of DPH matrix background in positive (a) and negative (b) ion modes.
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To determine the effectiveness of DPH as a MALDI matrix for fatty acids, three fatty acid standards,
hexanoic, palmitic and arachidic acids, were used as test analytes. As shown in Figures 2 a and b, the
expected deprotonated molecular ions of FA(16:0 and 20:0), [M–H]–, were observed as the most intense
peaks at m/z of 255.2 and 311.3 respectively. The DPH matrix signals were largely undetected, including
the deprotonated DPH ions (m/z of 231.2) previously observed in Figure 1 b. This suppression of matrix
background signals in the presence of analyte signals has been reported and extensively studied as matrix
suppression effect (MSE), in both positive8 and negative ion modes42 with other common MALDI matrices.
More discussion on this topic will be presented in the following section.
It is noteworthy that we were unable to obtain any signals of the shortest fatty acid tested, hexanoic acid.
We hypothesize that the six-carbon acyl chain was too short to favorably interact with DPH for optimal
analyte-matrix cocrystallization. DPH is commonly used for studying membrane bilayers consisting of
lipids with chain lengths of 12 or more carbons. Others had also reported that DPH could not detect the
presence of octanoic acid (8:0) in the membrane.43 Importantly, we also performed a comparison of DPH
with other commonly used matrices, using palmitic and arachidic acids as analytes. Higher signal intensities
were observed with DPH for both fatty acids (Supporting Information, Figure S-1).
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3x104

Relative Intensity (%)

100

(a)

200
100

600

400

800

1000
6x104
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Figure 2. Negative ion mode MALDI mass spectra of (a) palmitic acid and (b) arachidic acid using DPH
as a matrix.
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Next, we applied DPH for the MALDI MS detection of phospholipid standards. Table 1 lists the positive
ions, mainly as sodiated and/or protonated ions, and in negative ion mode, as their deprotonated ions [M–
H]–, and DLPC as the [M–CH3]– ion. The latter has been reported previously in phosphatidylcholine
detection using 9-AA as a matrix.44 While DPH facilitated the MALDI MS detection of all phospholipid
standards examined, the observed signal intensities were generally higher when analyzed in negative ion
mode (Supporting Information, Figure S-2). DPH is a neutral molecule with multiple double bonds, we
hypothesize that it behaves more favorably as a proton acceptor than a proton donor, and thus, analyte
ionization occurs mainly through the abstraction of protons. Hence, we focused our remaining work in
negative ion mode, and only the negative-ion MALDI-TOF mass spectra of these phospholipid standards
are presented (Supporting Information, Figure S-3). We suspect that the signal intensities of phospholipids
can be enhanced in the positive ion mode by addition of salt ions, but such investigation is out of the scope
of this paper.
Table 1. Positive and Negative Ions Observed in MALDI-MS for LPA, LPC, DMPA, DLPC, DSPE,
DSPG, and DOPS Standards Using DPH as a Matrix.
Analyte

Positive Ions

Ions

m/z observed

409.2

[M–H]–

[M+H]+

464.3

[M–CH3]–

615.4,

[M+Na]+,

591.4

[M–H]–

637.4

[M–H+2Na]+

622.4,

[M+H]+,

606.4

[M–CH3]–

644.4,

[M+Na]+,

666.4

[M–H+2Na]+

770.6,

[M+Na]+,

746.6

[M–H]–

792.6

[M–H+2Na]+

823.5,

[M–H+2Na]+,

777.6

[M–H]–

839.5,

[M–H+Na+K]+,

855.5

[M–H+2K]+

810.5,

[M+Na]+,

786.5,

[M–H]–,

832.5,

[M–H+2Na]+,

808.5

[M+Na–2H]–

854.5

[M–2H+3Na]+

[M+Na]+,

455.2,

[M–H+2Na]+,

477.2

[M–2H+3Na]+

LPC

480.3

DMPA

DLPC

DSPE

DSPG

DOPS

Ions

m/z observed

433.2,

LPA

Negative Ions
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While intense MALDI MS signals of phospholipids were observed in the negative ion mode using DPH,
we wanted to investigate how well DPH performs relative to other common matrices suitable for
phospholipids. A comparison was therefore performed on mixture of the four phospholipids, DMPA, DSPE,
DSPG and DOPS, using four matrices, DHB, 9-AA, DAN and DPH. The resulting MALDI mass negative
ion mode spectra and average signal-to-noise ratios (S/N) are presented in Figure S-4 (Supporting
Information) and Table 2. Interestingly, none of the four matrices appeared to provide a universal advantage
in promoting the S/N of these phospholipids. Instead, differences in selectivity or bias were observed.
Specifically, DMPA had the highest S/N with 9-AA, DSPE was strongest with DAN, DSPG was best
detected using DPH, and DOPS was most favorable with DHB. The optimal matrices for these four
phospholipids were underlined in Table 2. The result is not surprising and is likely related to different
degree of interaction for each matrix toward the different lipid molecules. While there was not a universal
enhancement in using DPH as a matrix for phospholipids, the main advantage of DPH lies in the superior
detection of fatty acids. Importantly, one should regard DPH as desirable for its ability to allow
simultaneous detection of both fatty acids (m/z ~ 200 – 350) as well as the larger phospholipids (m/z ~ 600
– 1000), which will be fully demonstrated in the imaging MS experiments in a later section. For the same
reason, we also did not compare the sensitivity of phospholipids using DPH in negative ion mode with that
using other matrices in positive ion mode.

Table 2: Average Signal-to-Noise Ratios and Standard Deviations (SD) from Triplicate MALDI MS
Analyses of DMPA, DSPE, DSPG. and DOPS Using 9-AA, DAN, DHB, and DPH as Matrices.
Matrix

DMPA (S/N)

DSPE (S/N)

DSPG (S/N)

DOPS (S/N)

m/z 591.4

m/z 746.6

m/z 777.6

m/z 786.5

9-AA

2958, SD 213

733, SD 60

4076, SD 137

3311, SD 97

DAN

2008, SD 114

5034, SD 46

6810, SD 239

2422, SD 87

DHB

53, SD 5

632, SD 13

2090, SD 43

4159, SD 66

DPH

1326, SD 24

2066, SD 37

8940, SD 214

1043, SD 34

Insight on the Cocrystallization and Matrix Suppression Effect (MSE):
McCombie and Knochenmuss proved the utility of MSE for the detection of low molecular weight
compounds in MALDI-MS, by optimizing the laser fluence and matrix-to-analyte molar ratios (m/a ratio).45
It has been also shown that analyte-matrix proximity is an important requirement to produce the MSE.8,42
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We aimed to explore this phenomenon and the influence of solvent on analyte signal using DPH. As a
fluorescence probe, typically used at a concentration range of 10–7 to 10–6 M, DPH can be dispersed in
aqueous media to form microaggregates, which are practically nonfluorescent. When such an aqueous
dispersion is mixed with lipids, the DPH molecules integrate and interact with the hydrophobic domain of
the lipids, and exhibit a dramatic increase in fluorescence.37 For our MALDI MS experiments, we
hypothesized that optimal cocrystallization between DPH and analyte can be achieved by promoting
proximity or intimate interactions. One way to achieve this is to use water in a similar fashion as in the
fluorescence experiments aforementioned. Specifically, the addition of water to a nonpolar environment
will drive the nonpolar DPH molecules toward the hydrophobic region of the analytes, such as fatty acids
or phospholipids in this case. To illustrate this effect, we performed MALDI MS analyses on a mixture of
three analytes, palmitic acid, arachidic acid and lyso-phosphatidic acid, using DPH as the matrix, with and
without the presence of water. The results are presented in Supporting Information (Figure S-5), where
weaker matrix background signals and slightly more intense analyte signals were observed in the presence
of water. This discovery supports our hypothesis of tighter interactions between DPH and the acyl chains
of lipids and fatty acids being essential to promoting efficient energy transfer during the MALDI process.
DPH Matrix for MS Imaging
After DPH has been ascertained as a suitable MALDI matrix for fatty acids and phospholipids, its
application in mass spectrometry imaging will be illustrated next. DPH is soluble in only selective solvent
such as THF or acetone. While the DPH solution in either THF or acetone works well for deposition with
micropipettes or automated sprayer, we are most interested in the application of DPH via sublimation,
which eliminates the use of solvents and thus minimizes the delocalization of analytes on the tissue,46
resulting in MSI data of high spatial resolution and reproducibility.47 However, for a matrix to be a useful
in MALDI MS imaging, it must remain relatively nonvolatile under vacuum. This was a limitation of
DMAN, which sublimes significantly at room temperature under vacuum, making it unsuitable for MSI.
To demonstrate the low volatility of DPH under vacuum, we loaded glass slides with DPH-coated tissue
sections into the mass spectrometer, and allowed them to sit at various time periods of 0, 6, 12, and 24 h
under vacuum (10–7 Torr), prior to acquiring the mass spectra (Supporting Information, Figure S-6). A total
of 70 main lipid peaks were detected and identified, no significant changes in overall signal intensities were
found. These results demonstrate the low volatility of DPH under high vacuum conditions for up to the 24
h tested.
Due to the high content and diversity of lipids in the central nervous system, brain tissues are excellent
samples for this work. Figure 3a presents the MALDI-TOF mass spectrum in the negative-ion mode
acquired from a coronal cerebellum mouse brain tissue section between the m/z range of 200 – 1000. In
12

general, signals from a diverse variety of lipids were observed. In this work, we are particularly interested
in the detection of fatty acids, since the existing common MALDI matrices are not optimal for such an
application. To illustrate the detection of fatty acids from brain tissue using DPH, Figure 3b shows the mass
spectrum focusing on the m/z range of 200 – 350 Da. The peaks at m/z 253.2, 255.2, 279.2, 281.2, 283.3,
303.2, 309.2, 327.3, 331.2, respectively, corresponding to palmitoleic acid (16:1), palmitic acid (16:0),
linoleic acid (18:2), oleic acid (18:1), stearic acid (18:0), arachidonic acid (20:4), gadoleic acid (20:1),
docoshexaenoic acid (22:6), and docosatetraenoic acid (22:4) were observed. Moreover, we noticed an
optimal matrix suppression effect in this case where nearly zero matrix background ions were observed.

FAs

100

PSs + STs

Relative Intensity (%)

(a)

Lyso-PSs

200

Relative Intensity (%)

100

m/z 281.2
FA(18:1)

m/z 255.2
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(b)

m/z 283.3
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Figure 3: Negative ion mode MALDI-TOF mass spectra acquired from coronal cerebellum mouse brain
section coated with DPH via sublimation, showing the full m/z range of 200 – 1000 (a) and the m/z range
of 230 – 350 focusing on fatty acids (b).
The intense S/N observed in Figure 3 allows us to obtain MS images of various fatty acids and lipids at
extremely high quality. The ion images of selected fatty acids and phospholipids are presented in Figure 4,
which show the structure of coronal cerebellum mouse brain section with distinguishable localization of
ion distribution in different compartments such as cerebellar lobuls, middle cerebellar penducle, and fourth
ventricle.
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Figure 4. MALDI-MS images of coronal cerebellum mouse brain section (Interaural –1.08, Bregma
–10.08, Paxinos and Watson Atlas) coated with DPH by sublimation acquired in negative-ion mode, spatial
resolution at 80 µm.

In Figure 5, the MALDI-MS images of coronal hippocampus rat brain section indicate that many sulfatides
(STs) species were detected: m/z 778.5, 806.5, 878.6, 862.5, 888.6, 904.6, and 906.6. They were found to
be more abundant in the white matter (corpus callosum) than in the hippocampus and cortex. This
characteristic distribution is in agreement with previously published work.48 In addition, we were able to
detect small peaks at 822.5, 834.6, 850.6, 916.7, 918.7, 932.6, and 934.7, and they all exhibited similar
distribution patterns (data not shown).
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Figure 5: MALDI MS images of coronal hippocampus section of rat brain (Interaural 5.64, Bregma –3.36,
Paxinos and Watson Atlas) acquired in negative-ion mode using sublimated DPH as matrix, spatial
resolution 70 µm.
As demonstrated in Figures 4 and 5 and the additional Figure S-7 (Supporting Information) showing
two serial sagittal sections of the same mouse brain, MSI using DPH as the matrix provided a
significant amount of information on the distribution and abundance of a number of fatty acids and
lipids in diffferent anatomical regions including cortex, corpus callosum, hippocampus, caudate
putamen (striatum), and lateral ventricle.
Despite the high-quality images shown in the above figures, it is acknowledged that the fatty acid signals
measured by mass spectrometry may come from endogenous free fatty acids as well as fatty acids
dissociated from phospholipids during ionization. This is a general limitation of mass spectrometry and is
not directly related or affected by the choice of MALDI matrix. Others have attempted to differentiate
between the free and dissociated forms of fatty acids by chemically labeling the free fatty acids with
esterification.30 Unfortunately, it was unsuccessful due to the hydrolysis of phospholipids during the
derivatization process.
To gauge the level of phospholipid fragmentation in our work with DPH, we first performed MALDI MS
measurements on DMPA standards at various laser intensities, since high laser energies is known to
promote fragmentation of analytes.49-51 The results in Figure S-8 (Supporting Information) illustrate that
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myristic acid resulted from fragmentation of DMPA was not detected at the lowest laser energy (Figure S8a). With higher laser energies, increasing intensities of myristic acid and decreasing intensities of intact
DMPA were observed. In the worst-case scenario, at the highest laser energy examined, all of the DMPA
were fragmented (Figure S-8e). Based on this set of data, the use of low laser energy is preferred for the
suppression of phospholipid fragmentation, although it needs to be sufficiently high to induce analyte
ionization.
In the next experiment, spots of DSPG (m/z 777.6) and DSPE (m/z 746.6) standards were deposited on
mouse brain tissue. After DPH sublimation, the degree of fragmentation was determined at three laser
intensities, 2600, 2700, and 2800. The strongest fragment peaks resulted from these lipids were at m/z 493.3
and 462.6, respectively, which corresponded to the loss of one fatty acid chain (stearic acid, C18). The
results are presented in Supporting Information, Figure S-9a, and it confirms that the level of lipid
fragmentation increased with higher laser energies. In Figure S-9b, we plotted the signals of deprotonated
stearic acid (m/z 283.3) on the spiked spots of DSPG and DSPE, which likely resulted from the
fragmentation of DSPG and DSPE. For comparison, we showed intensities of the “endogenous” 283.3 peak
from the tissue (outside of the spiked spots), which increased with increasing laser energies. In addition,
we displayed the signals from two larger lipids, m/z 885.5 from phosphoinositol (18:0/20:4) and m/z 888.6
from sulfatide (18:1/24:1) detected from the tissue, to illustrate the decreasing signals of intact
phospholipids at higher laser intensities. The data in Figure S-9 collectively illustrated that lower laser
energy, 2600 in this case, is favorable in minimizing the fragmentation of phospholipids. Laser energies
below 2600 was also tested, but poor sensitivity was generally resulted. Consequently, all of the tissue
imaging data presented in this paper was collected at a laser energy of 2600. While we are unable to claim
that the fatty acids detected at this low laser energy were all endogenous free fatty acids, we are confident
that most of them were indeed free fatty acids. Importantly, one may also collect parallel MS images at
high laser energy; such as 2800 in this case. Based on changes in fatty acid distribution between low and
high laser energy, one may be able to differentiate the endogenous fatty acid from fragments of
phospholipids.
On-Tissue Structural Identification of Lipids by Tandem Mass Spectrometry. As the final section of
this paper, we investigated the performance of DPH as a matrix in facilitating on-tissue tandem MS analysis
of lipids. We began our studies by evaluating the fragmentation patterns of lipid standards under MALDI
tandem MS using DPH as a matrix. As demonstrated in Figure S-10 (Supporting Information), DMPA and
DSPG produced very clean spectra with easily identifiable fragments. Next, we conducted tandem MS on
the intense lipid signals detected from tissue sections, with DPH applied via sublimation. Thanks to the
highly sensitive detection of lipids from the tissue, tandem MS characterization was successfully achieved
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on-tissue. As demonstrated in Figure 6, the precursor ion with m/z 885.5 was fragmented into product ions
with m/z 439.2, 419.2, 303.2, 283.3, 259.2, and 241.0. The fragment ion of m/z 439.2 corresponds to a
molecule generated by a neutral loss of arachidonic acid (20:4, 304 Da) and inositol phosphate (162 Da;
C6H10O5). Another fragment ion of m/z 419.3 came from the neutral loss of stearic acid (18:0, 284 Da) and
inositol from [M–H]- of precursor ion. The two peaks of m/z 283.3 and 303.2 correspond to the [M-H]- ions
of stearic and arachidonic acid, respectively. Fragment ion m/z 259 is inositol phosphate ion, and m/z 241
is the headgroup of inositol phosphate ion with loss of H2O. These results collectively confirm the parent
molecule of m/z 885.5 as phosphatidylinositol (PI 18:0/20:4). Interestingly, one may notice the fragment
ion peak intensity of arachidonate derived from the sn-2 position being significantly higher than that of
stearate derived from the sn-1 position. The same was observed from the two peaks of m/z 439 and 419
that correspond, respectively, to the complementary fragment of each fatty acids.
Similar to PI, fragmentation of other phospholipid classes such as PE, PG, and PA also yields specific
diagnostic fragment peaks corresponding to their specific fatty acids, and, thus, allowing the identification
of isobaric lipid molecules. Figure S-11 (Supporting Information) shows the MS/MS spectrum of the
precursor ion of m/z 747.5, which represents two isobaric molecules PA (18:0/22:6) and PG (16:0/18:1).
Through the above examples, we demonstrated that the use of DPH as a MALDI matrix was highly effective
in facilitating tandem MS analysis that led to the definitive structural assignments of lipids, specifically
through the multiple informative fragment ions including the fatty acids fragments.

303.2

Relative Intensity (%)

100

241.0
283.3

419.2

259.2
97.0

153.0

200

439.2
400

m/z

600

800

Figure 6. Tandem mass spectrum generated from the precursor ion of m/z 885.5 (PI 18:0/20:4).
Supporting Information, Table S-1, lists the relatively high intensity mass peaks observed in the negativeion MALDI-TOF-mass spectra within the m/z range of 200 – 1000, acquired from coronal cerebellum
mouse. The table shows the assignment for each peak, based on both MS and tandem MS data, as described
in Materials and Methods. In summary, DPH allowed the detection of 11 fatty acids, 14 lyso-phospholipids
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and lyso-sulfatide,52 3 phosphatidic acids, 16 phosphoethanolamines, 4 phosphatidylserines, 2
phosphatidylglycerols, 3 phosphatidylinositols, and 16 sulfatides. There were also many other low intensity
peaks that resulted in seemingly meaningful MS images, but were not yet identified for this paper.

Conclusions
We have successfully demonstrated the application of commercially available DPH as a new MALDI
matrix for the detection of fatty acids and a variety of lipids. The matrix was found to be more effective in
producing intense signals in the negative ionization mode. Based on our understanding derived from this
work, the hydrophobic polyene structure and its favorable interaction with the acyl chain were responsible
for the ideal characteristics of DPH as a matrix. Two additional features of DPH, namely, compatibility
with sublimation matrix application and low volatility in vacuum, make it an ideal matrix for MALDI MS
imaging. By keeping the laser power relatively low, we were able to minimize fragmentation of
phospholipids and obtain high quality MALDI MSI data in the negative ion mode. This allows the
simultaneous visualization of both fatty acid and the lipid distributions from mouse and rat brain tissues,
including fatty acids, lyso-phospholipid, phosphatidic acid, phosphoethanolamine, phosphatidylserine,
phosphatidylglycerol, phosphatidylinositol, and sulfatides. Finally, we demonstrated the highly effective
on-tissue tandem MS analysis of lipids detected from the tissue. DPH facilitated the fragmentation of lipids
in a simple and easily identifiable fashion, in turn allowing the fragment information to be used for structural
characterization of the precursor ions.
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